Piramal Enterprises (Delisted) share news and announcements
BSE: 500302Finance
Formerly Piramal Healthcare
Last traded ₹1,124.20 on 22 Sep 2025
Delisted on 16 Jan 2026.
Piramal Enterprises share news and announcements
3,280 announcements, routine notices left out, newest first. Page 62 of 66.
Sep 2010
1 Sep · Disclosure
Adelwise Investments Private Limited had submitted to the Exchange a copy of Disclosure under Regulation 3(3) of Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 1997. The Company has now informed the Exchange that "We do not wish to proceed with the proposed acquisition of shares of Piramal Healthcare Limited".
Aug 2010
23 Aug · Updates
Piramal Healthcare Limited had informed the Exchange that the Company has signed a definitive agreement under which, Super Religare Laboratories Limited ('SRL') would acquire Piramal Diagnostic Services Private Limited ("PDSL"), a subsidiary of the Company. The Company has now informed the Exchange vide its letter dated August 21, 2010, that the Company has now completed the divestiture of its shareholding in PDSPL to SRL.21 Aug · Piramal Healthcare completes the divestiture of its shareholding in its subsidiary - Piramal Diagnostic Services Pvt. Ltd.
With reference to the earlier announcement dated July 14, 2010 informing that Piramal Healthcare Ltd. ('the Company') has signed a definitive agreement under which, Super Religare Laboratories ....10 Aug · Results
Standalone Results for the quarter ended on 30-JUN-2010 as follows: Net Sales of Rs. 57036 lacs for quarter ending on 30-JUN-2010 against Rs. 56973 lacs for the quarter ending on 30-JUN-2009. Net Profit / (Loss) of Rs. 6691 lacs for the quarter ending on 30-JUN-2010 against Rs. 7411 lacs for the quarter ending on 30-JUN-2009.10 Aug · Results
Consolidated Results for the quarter ended on 30-JUN-2010 as follows: Net Sales of Rs. 84241 lacs for quarter ending on 30-JUN-2010 against Rs. 82154 lacs for the quarter ending on 30-JUN-2009. Net Profit / (Loss) of Rs. 8074 lacs for the quarter ending on 30-JUN-2010 against Rs. 8510 lacs for the quarter ending on 30-JUN-2009.
Jul 2010
30 Jul · Board meeting
To consider and take on record the Unaudited Financial Results (consolidated and standalone) of the Company for the 1st quarter ended June 30, 2010.30 Jul · Results
Meeting of the Board of Directors of the Company will be held on August 10, 2010, to consider and take on record the Unaudited Financial Results ....22 Jul · Meeting
Members at the 63rd Annual General Meeting (AGM) of the Company held on July 09, 2010, inter alia, have passed the following resolutions: ....14 Jul · Meeting
Brief summary of the business transacted at the AGM held on July 09, 2010: 1)The Audited Accounts for the year ended March 31, 2010 were adopted; 2)Dividend at Rs. 5.40 per equity share of Rs.2/- (i.e. @ 270%) on 20,90,13,144 Equity Shares was declared for the financial year ended March 31, 2010; 3) Mr. R. A. Shah and Mr. N. Vaghul have been reappointed as Directors of the Company; 4) M/s. Price Waterhouse, Chartered Accountants, Mumbai have been reappointed as Auditors of the Company. Special Business: a) Special Resolution for payment of commission to Non-Executive Directors at the rate upto 1 percent of the net profits of the Company in each year for a further period of 5 years commencing from the Company's financial year ending March 31, 2011 was duly passed; b)Special Resolution for re-appointment of Mr. N. Santhanam as Executive Director & Chief Operating Officer, not liable to retire by rotation, for a period of 3 years with effect from October 25, 2010 was duly passed; c) Special Resolution for keeping of register and index of members and debenture-holders with the Company's Share Transfer Agents for the time being, who presently are Link Intime India Private Limited having their office at C-13, Pannalal Silk Mills Compound LBS Marg, Bhandup (West), Mumbai - 400 078 was duly passed.14 Jul · Piramal Healthcare Ltd to sell Piramal Diagnostic Services Private Ltd to Super Religare Laboratories
Jun 2010
22 Jun · Piramal Healthcare Limited to acquire assets of BioSyntech, a biotechnology company developing novel products in regenerative medicine